A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Mayo Clinic
Case Comprehensive Cancer Center
Massive Bio, Inc.
Incyte Corporation
Shwachman-Diamond Syndrome Alliance Inc
Karyopharm Therapeutics Inc
Stanford University
BerGenBio ASA
Stanford University
Cancer Support Community, Research and Training Institute, Philadelphia
OHSU Knight Cancer Institute
Sumitomo Pharma America, Inc.
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Incyte Corporation
CureOne
Stanford University